# Ei LLC, Kannapolis, NC – FDA Inspections

Source: https://www.keypedia.com/companies/ei-llc/88b53134-ac99-4eb2-b709-2a80a826ad7d

> Inspection records and compliance data for Ei LLC in Kannapolis, North Carolina. 8 FDA inspections on record (1 OAI), 1 Form 483, 1 warning letter, last inspected October 06, 2017.

---

## Details

- Name: Ei LLC
- FEI Number: 3005832998
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE
- Address Line 1: 2865 N Cannon Blvd
- City: Kannapolis
- State: North Carolina
- Zip Code: 28083
- Country Name: United States
- Address: 2865 N Cannon Blvd, Kannapolis, North Carolina 28083, United States
- Country: United States

## Related Documents

- [WARNING_LETTER - Ei LLC - 2017-10-06](https://www.keypedia.com/records/warning_letter/ei-llc/b6042281-ab78-4338-b962-4b8f39501576) — source: FDA, date: October 6, 2017
- [FDA Inspection 1028163 - Ei LLC - 2017-10-06](https://www.keypedia.com/records/fda_inspections/ei-llc/bc3fa7b3-151f-42c0-815f-3c21cc73bdcb) — classification: Official Action Indicated (OAI), source: FDA, date: October 6, 2017
- FDA Inspection 1028163 - Ei LLC - 2017-10-06 — classification: Official Action Indicated (OAI), source: FDA, date: October 6, 2017
- [FDA Inspection 925800 - Ei LLC - 2015-05-08](https://www.keypedia.com/records/fda_inspections/ei-llc/f69030db-51d3-4c57-ac23-96e808fd99ea) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 8, 2015
- FDA Inspection 870367 - Ei LLC - 2014-02-26 — classification: No Action Indicated (NAI), source: FDA, date: February 26, 2014
- FDA Inspection 799551 - Ei LLC - 2012-09-19 — classification: No Action Indicated (NAI), source: FDA, date: September 19, 2012
- FDA Inspection 745354 - Ei LLC - 2011-09-15 — classification: No Action Indicated (NAI), source: FDA, date: September 15, 2011
- FDA Inspection 729179 - Ei LLC - 2011-05-25 — classification: No Action Indicated (NAI), source: FDA, date: May 25, 2011
- FDA Inspection 618445 - Ei LLC - 2009-08-27 — classification: No Action Indicated (NAI), source: FDA, date: August 27, 2009
- FDA Inspection 572457 - Ei LLC - 2009-02-13 — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 13, 2009

## Related Companies

- [Teva Pharmaceuticals USA, Inc](https://www.keypedia.com/companies/teva-pharmaceuticals-usa-inc/16ce5163-b7e9-4f34-adce-197945dc8b53)
- [Eisai, Inc.](https://www.keypedia.com/companies/eisai-inc/081df088-ce18-4702-a2b3-cb4e48ebe3e4)
- [Cody Laboratories, Inc.](https://www.keypedia.com/companies/cody-laboratories-inc/ff687af7-da97-441d-b0cd-7f20af5e87a9)
- [Taro Pharmaceuticals U.S.A., Inc.](https://www.keypedia.com/companies/taro-pharmaceuticals-usa-inc/05da273e-af73-473f-a144-af7c4e2972c9)
- [Lambda Therapeutic Research Ltd.](https://www.keypedia.com/companies/lambda-therapeutic-research-ltd/e4515c16-4ff4-451a-9d2f-b4b1668eb47c)
- [Actavis Italy Spa A Socio Unico](https://www.keypedia.com/companies/actavis-italy-spa-a-socio-unico/7c4ac702-d647-4c5d-a853-472db165127e)
- [Sagent Pharmaceuticals](https://www.keypedia.com/companies/sagent-pharmaceuticals/9b7830c1-51dd-4d82-8287-b320eff537fd)
- [David L. Wirta, M.D.](https://www.keypedia.com/companies/david-l-wirta-md/f239b2b9-d44b-4aa0-b2e3-3506e3831bae)
- [AltaSciences Clinical Los Angeles Inc.](https://www.keypedia.com/companies/altasciences-clinical-los-angeles-inc/977107a9-0682-40d1-b775-8c0cb8c7e822)
- [Bausch Health Americas, Inc.](https://www.keypedia.com/companies/bausch-health-americas-inc/46368cf4-fd1b-4ed0-a010-ae5ccd022cb6)

## Related Officers

- [Ms.](https://www.keypedia.com/people/kathryn-weingart/5cf95fa4-b860-47dc-8449-b37be76dbed2)
- [Program Division Director](https://www.keypedia.com/people/monica-r-maxwell/e1b3373a-80b0-4023-9aea-b4ac7170c964)
